C45H57NO14
835.9 g/mol
Aktif Farmasötik İngredientTehlike
Jevtana
Kabazitaksel
CAS183133-96-2
Kategori
Aktif Farmasötik İngredient
Bileşik Sınıfı
Ester
Birincil Kullanım
Farmasötik ham madde
Jevtana is the brand name for cabazitaxel, an active pharmaceutical ingredient used in drug manufacturing. It functions as a microtubule inhibitor and is investigated for antineoplastic activity.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 183133-96-2
İlgili Bileşikler
GüçlüAynı ana yapı
((1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-15-((2R,3S)-2-hydroxy-3-((2-methylpropan-2-yl)oxycarbonylamino)-3-phenylpropanoyl)oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.03,10.04,7)heptadec-13-en-2-yl) benzoate;propan-2-one
CAS1426815-65-7
active pharmaceutical ingredient
BenzerBenzer yapıBenzerlik 0.83
Docetaxal
CAS125354-16-7
active pharmaceutical ingredient
BenzerBenzer yapıBenzerlik 0.79
Docetaxel
CAS114977-28-5
active pharmaceutical ingredient
BenzerBenzer yapıBenzerlik 0.79
Docetaxel trihydrate
CAS148408-66-6
active pharmaceutical ingredient
ReferansAynı kategori
Upadacitinib
CAS1831899-72-9
Janus kinase inhibitor active pharmaceutical ingredient
ReferansAynı kategori
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride
CAS183204-72-0
active pharmaceutical ingredient
ReferansAynı kategori
Clindamycin
CAS18323-44-9
semi-synthetic lincosamide antibiotic
ReferansAynı kategori
Erlotinib hydrochloride
CAS183319-69-9
active pharmaceutical ingredient
Güvenlik Referansı
Tehlike
H302Harmful if swallowed
H311Toxic in contact with skin
H315Causes skin irritation
H317May cause an allergic skin reaction
H318Causes serious eye damage
H335May cause respiratory irritation
H341Suspected of causing genetic defects
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
H362May cause harm to breast-fed children
H372Causes damage to organs through prolonged or repeated exposure
H373May cause damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
Tanımlayıcılar
IUPAC Adı
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
InChIKey
BMQGVNUXMIRLCK-OAGWZNDDSA-N
SMILES
CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC
Eş Anlamlılar (33)
- EX-A838
- Cabazitaxel (USAN/INN)
- AB01273971-01
- CABAZITAXEL [MART.]
- Cabazitaxel (Jevtana)
- Cabazitaxel (Standard)
- Cabazitaxel Injection
- Cabazitaxelum
- Jevanta
- Jevtana
- Jevtana (TN)
- Jevtana Kit
- RPR-116258A
- TXD 258
- Taxoid XRP6258
- Xrp6258
- cabazitaxel acetonate
- kabazitaxel